NYU Abu Dhabi gastric stent targets repeat procedures after AED 25K-50K bariatric surgery

New York University Abu Dhabi researchers have developed a biodegradable 3D-printed gastric stent that could reduce repeat procedures for patients who develop leaks after weight-loss surgery, according to The National on 27 August 2026.

The immediate value is for COOs, CFOs and medical directors running bariatric programmes in Dubai, Abu Dhabi and the northern emirates. The device, called BRIDGE (Biodegradable aRchitected Internal DrainaGE), is designed for one of the complications that can turn an elective obesity procedure into a prolonged inpatient case. In Dubai, bariatric providers sit under the Dubai Health Authority (DHA). In Abu Dhabi and Al Ain, oversight sits with the Department of Health Abu Dhabi (DOH). In the northern emirates, providers operate under the Ministry of Health and Prevention (MOHAP) licensing framework, while medical device market access is now a federal approval issue.

What NYU Abu Dhabi has built

NYU Abu Dhabi said the stent uses a redesigned internal lattice and biodegradable materials to improve drainage and then break down after treatment. The work was developed in collaboration with Cleveland Clinic Abu Dhabi and published in Device. The university said laboratory testing showed more than double the drainage performance of conventional stents and resistance to bends more than seven times tighter without kinking.

"By combining advanced 3D printing with biodegradable materials, we created a stent that improves drainage while reducing the burden of treatment for patients," Parima Phowarasoontorn, research assistant in the Ramadi Lab at NYU Abu Dhabi, said in the university statement.

The key caveat is operational. The device is not a product that UAE hospitals can schedule tomorrow. The National reported that BRIDGE needs further research before it can be used on patients. For procurement teams, that means no tender, preferred supplier decision or insurer pathway should be built until there is clinical evidence, device approval and a reimbursement position.

Why clinics and insurers should track it

Bariatric surgery is already a material private-sector line item in the UAE. Published UAE hospital packages show sleeve gastrectomy and bypass prices commonly advertised from AED 14,000 at Fakeeh University Hospital to AED 35,000 and AED 40,000 at Mediclinic for selected package pathways. Al Zahra Hospital Dubai lists bariatric packages including sleeve gastrectomy at AED 29,000 and mini gastric bypass at AED 32,000. Revision procedures can run higher; Mediclinic lists revision gastric sleeve at AED 45,000 and revision gastric bypass at AED 50,000.

A gastric leak can change the cost profile because it may require imaging, endoscopy, drainage, antibiotics, intensive monitoring, transfer, or a longer stay. Those items are often outside fixed surgical packages. Insurers such as Daman, Thiqa and Sukoon should treat BRIDGE as a future complication-management question, rather than a weight-loss benefit question. The actuarial issue is avoidable repeat endoscopy and bed days after a covered or self-paid operation.

• COOs should map current leak pathways: on-call endoscopy, interventional radiology access, ICU escalation and transfer agreements.
• CFOs should separate package revenue from excluded complication costs in bariatric service-line reporting.
• Medical directors should document who decides between stenting, drainage, reoperation and referral to a tertiary centre.
• CIOs should ensure bariatric registries capture leak timing, stent use, removal procedures and readmissions.

What happens before patient use

The regulatory route matters. A biodegradable gastric stent would need UAE medical device approval before routine clinical use, with facility-level adoption then governed by local health authority licensing and scope. DHA standards for bariatric services were circulated to Dubai facilities in 2023. DOH has a published standard for bariatric surgery centres of excellence in Abu Dhabi. MOHAP remains relevant for northern-emirates providers and federal health licensing, while market entry for devices requires the current federal device approval route.

Eligibility for bariatric surgery also shapes demand. UAE providers generally cite thresholds around BMI 40, or BMI 35 with obesity-related disease, with some Asian-population thresholds lower in Dubai bariatric standards. Clinics should verify eligibility criteria against the latest DHA, DOH or MOHAP rules before marketing any procedure or complication pathway.

The next checkable milestone is a human clinical study, followed by UAE device approval and payer coding. Until then, the practical move is internal audit: count post-bariatric leaks, repeat endoscopies, average length of stay and excluded package costs over the past 12 months. Patients looking for licensed nutrition and dietetics support before or after bariatric care can use the UAE Open Healthcare Directory to find regulated providers in Dubai, Abu Dhabi and the northern emirates.